These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 5298482)
1. Studies on the open negative syndrome resulting from chemotherapy with secondary anti-tuberculosis agents. Kimura Y Jpn J Tuberc; 1966 Dec; 13():Suppl:71-6. PubMed ID: 5298482 [No Abstract] [Full Text] [Related]
2. [Symposium on the open negative syndrome. 5. Studies on the open negative syndrome occurring after chemotherapy with secondary antituberculous drugs]. Kimura Y Kekkaku; 1966 Aug; 41(8):383-6. PubMed ID: 5975306 [No Abstract] [Full Text] [Related]
3. [Symposium on the open negative syndrome. 4. Study on the prognosis of the open negative syndrome occurring after chemotherapy with primary anti-tuberculous drugs]. Fujioka M; Yoshida F; Komoto H; Takahashi O; Nishiyama K Kekkaku; 1966 Aug; 41(8):381-3. PubMed ID: 5975305 [No Abstract] [Full Text] [Related]
4. [Efficacy of chemotherapy of pulmonary tuberculosis drug-resistant m.tuberculosis]. Khomenko AG; Chukanov VI; Korneev AA Probl Tuberk; 1996; (6):42-4. PubMed ID: 9019768 [TBL] [Abstract][Full Text] [Related]
6. "Open-negative" syndrome. Clinical course of its development and subsequent destiny. Miyagi Y Jpn J Tuberc; 1966 Dec; 13():Suppl:54-9. PubMed ID: 5298479 [No Abstract] [Full Text] [Related]
7. The chemotherapy of tuberculosis in Bulgaria today. Nitchev V Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):156-8. PubMed ID: 2999953 [No Abstract] [Full Text] [Related]
8. [Symposium on the open negative syndrome. 2. Formation of the open negative cavity during the course of original treatment and the fate of the cavity]. Miyagi Y Kekkaku; 1966 Aug; 41(8):375-8. PubMed ID: 5975303 [No Abstract] [Full Text] [Related]
9. [Clinical limits of microbial resistance to secondary antitubercular agents]. Sakurai H; Hashimoto T Saishin Igaku; 1966 Jan; 21(1):88-94. PubMed ID: 5965948 [No Abstract] [Full Text] [Related]
10. [Observations on antituberculous drug-resistance among pulmonary tuberculosis patients at the National Sanatoria in Kyushu district. 3. The secondary anti-tuberculosis agents (kanamycin, cycloserine, ethionamide)]. Yamaguchi S Iryo; 1968 Oct; 22(10):1115-9. PubMed ID: 5715475 [No Abstract] [Full Text] [Related]
12. [Follow-up studies on patients with chronic pulmonary tuberculosis treated with secondary tuberculostatic agents]. Böszörményi M; Faust I; Barát I; Schweiger O Probl Tuberk; 1965; 43(8):39-45. PubMed ID: 5869918 [No Abstract] [Full Text] [Related]
13. [Pulmonary tuberculosis with cavitation]. Aoyagi T Naika; 1967 Nov; 20(5):908-15. PubMed ID: 5599392 [No Abstract] [Full Text] [Related]
14. [Tuberculosis chemotherapy in cases of resistance]. Troi K; Marcocci S Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():477-8. PubMed ID: 6417641 [No Abstract] [Full Text] [Related]
15. [Syndrome of "open cavity healing". (Analysis of late results of treatment)]. Zierski M Gruzlica; 1967 Mar; 35(3):219-26. PubMed ID: 6041224 [No Abstract] [Full Text] [Related]
16. [Evaluation of the infectiousness of initially open pulmonary tuberculosis with reference to enforced isolation]. Breu K Med Monatsschr; 1970 May; 24(5):198-201. PubMed ID: 4997660 [No Abstract] [Full Text] [Related]
17. [Chemotherapy of tuberculosis]. Bartmann K Dtsch Med J; 1968 Dec; 19(24):845-50. PubMed ID: 5719335 [No Abstract] [Full Text] [Related]
18. [Problems and prospects of antitubercular chemotherapy at the present time]. Nitti V Arch Monaldi; 1970; 25(2):115-26. PubMed ID: 5510341 [No Abstract] [Full Text] [Related]
19. The modern treatment of pulmonary tuberculosis. Costello J Postgrad Med J; 1983; 59 Suppl 3():181-4. PubMed ID: 6417637 [No Abstract] [Full Text] [Related]
20. [Method of measuring microbial resistance to secondary antitubercular drugs]. Ogawa M Saishin Igaku; 1966 Jan; 21(1):76-87. PubMed ID: 5338044 [No Abstract] [Full Text] [Related] [Next] [New Search]